ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko00600	Sphingolipid metabolism	3/21	63/7206	0.000757096665429
ko04071	Sphingolipid signaling pathway	4/21	162/7206	0.00109259835115
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	2/21	28/7206	0.0029212629625
ko01521	EGFR tyrosine kinase inhibitor resistance	3/21	106/7206	0.00339340893491
ko01522	Endocrine resistance	3/21	124/7206	0.00527425846876
ko04722	Neurotrophin signaling pathway	3/21	160/7206	0.0106513456326
ko05161	Hepatitis B	3/21	173/7206	0.0131597621547
ko05213	Endometrial cancer	2/21	62/7206	0.0137694654485
ko05221	Acute myeloid leukemia	2/21	63/7206	0.0141961004905
ko04210	Apoptosis	3/21	180/7206	0.0146400436902
ko05223	Non-small cell lung cancer	2/21	66/7206	0.0155102396092
ko04072	Phospholipase D signaling pathway	3/21	197/7206	0.0186193093913
ko05014	Amyotrophic lateral sclerosis (ALS)	2/21	74/7206	0.0192597997956
ko01524	Platinum drug resistance	2/21	76/7206	0.0202514914783
ko04370	VEGF signaling pathway	2/21	77/7206	0.0207553043986
ko03008	Ribosome biogenesis in eukaryotes	2/21	79/7206	0.0217787044916
ko05220	Chronic myeloid leukemia	2/21	85/7206	0.0249728209446
ko05218	Melanoma	2/21	85/7206	0.0249728209446
ko05210	Colorectal cancer	2/21	86/7206	0.0255229158758
ko04012	ErbB signaling pathway	2/21	109/7206	0.039490427114
ko05215	Prostate cancer	2/21	111/7206	0.0408177655498
ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	1/21	15/7206	0.0428738109696
ko05203	Viral carcinogenesis	3/21	277/7206	0.0447866852317
ko04211	Longevity regulating pathway	2/21	123/7206	0.0491313924035